BioClinica Strengths, Domain Expertise, and Key Differentiators
Bioclinica is the leader in scientifically-driven services and technology-enabled solutions in clinical research. BioClinica launched the BioClinica eHealth Cloud, a flexible and highly configurable platform offering. The eHealth Cloud offers unlimited accessibility and a variety of delivery options to better meet the current and future needs of both preapproval and post-approval research. With public consumer, private cloud managed cloud, and custom options, the eHealth Cloud offers the right hosting subscription model to meet the specific needs of individual clinical trials.
BioClinica's extensive and highly interoperable clinical trials platform, that includes Express EDC, Trident RTSM, Optimizer Supply Forecasting and Simulation, OnPoint CTMS and Compass Intelligent Risk-Based Monitoring solution, will be optimized for delivery through the eHealth Cloud. Furthermore, these powerful trial solutions will provide unprecedented integration capabilities through the BioClinica Cloud Transformation Gateway, a secure standards-based integration exchange that connects BioClinica's eClinical Platform to innovative third-party applications and industry data banks.
BioClinica Recent Developments
BioClinica assists the life science industry with the announcement of a a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides a Clinical Endpoint Committee solution. This solution combines world-class medical expertise, an experienced adjudication management team, and a cutting-edge endpoint adjudication platform to help pharmaceutical and medical device researchers discern COVID-related adverse events from those not associated with COVID-19.
In June 2018, Bioclinica, a global life sciences services provider that utilizes science and technology to bring clarity to clinical trials, introduced it's expanded and enhanced SMART technology suite available with Medical Imaging, Electronic Data Capture (EDC) and Interactive Response Technology (IRT) combined. Bioclinica's proven, synchronous clinical trial technologies converge all essential activities in a common data set. Investigative sites can now access Medical Imaging, EDC and IRT data via a single, easy-to-use portal where they can view, analyze and act on the data. Implementation is underway by a major pharmaceutical company and a leading CRO who are using Bioclinica's enhanced SMART technology for its global trial portfolio.
BioClinica Mergers and Acquisitions (M&A) Activities
In October 2018, Cinven completed the acquisition of Bioclinica, a global provider of clinical trial services and technology to contract research organizations (CROs) and pharmaceutical companies, for an undisclosed consideration. Cinven's healthcare team identified Bioclinica as a compelling investment opportunity given the team's strong track record in the clinical trials sector and direct experience through its investment in Medpace, a leading CRO business. Bioclinica operates in a number of high growth areas to improve the efficiency and productivity of clinical trials. Bioclinica benefits from structural factors including as growing clinical trial activity increased outsourcing and the adoption of clinical software services.
BioClinica Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying BioClinica applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of BioClinica and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified Bioclinica Cloud, eHealth App xChange, eHealth Cloud, customers.
Ownership: - Cinven
Number of Employees: 3000
Functional Markets: ERP Services and Operations Management,
BioClinica Key Enterprise and Cloud Applications
Bioclinica Cloud, eHealth App xChange, eHealth Cloud,
BioClinica Revenues, $M:
|Type/Year||2018||2019||YoY Growth, %|
|Total Revenues, $M||Subscribe||Subscribe||Subscribe|
|Enterprise Applications Revenues, $M||Subscribe||Subscribe||Subscribe|
|Cloud Applications Revenues, $M||Subscribe||Subscribe||Subscribe|
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
BioClinica Revenue Breakdown By Type, $M:
|Type||License||Services||Hardware||Support & Maintenance||SaaS|
|% of Total Revenues||Subscribe||Subscribe||Subscribe||Subscribe||Subscribe|
BioClinica Enterprise Applications Revenues By Functional Markets, $M:
BioClinica Enterprise Applications Revenues By Verticals, $M:
BioClinica Revenues By Region, $M
|Region||% of Total Revenues||2019 Total Revenues, $M||2019 Enterprise Applications Revenues, $M||2019 Cloud Applications Revenues, $M|
BioClinica Direct vs Indirect sales
|Region||Direct Sales||Indirect Sales||Total|
BioClinica Customers - Breakdown by Geo, Size, Vertical and Product
No. of BioClinica Customers: 500
No. of BioClinica Enterprise Applications Customers: 500
No. of BioClinica Cloud Customers: x
No. of BioClinica Cloud Subscribers: x
BioClinica has over 500 Clients Including all of the Top 20 Pharmaceutical and Biotech Companies. Among its customers are Pfizer Inc, ClinPlan, Millennium Pharmaceutical, Luitpold Pharmaceuticals, and many others.
BioClinica Market Opportunities, M&A and Geo Expansions
Bioclinica acquired MDDX Research & Informatics, adding cloud research image management and submission technologies to its suite of eHealth solutions. MDDX cloud-based image submission technology will become the backbone of Bioclinica's SMART solution. SMART, which stands for Submit, Manage, Analyze, Report, and Transfer, is a robust suite of centralized medical imaging services designed to manage the complex imaging process from image receipt and analysis to regulatory submission.
In 2016, BioClinica acquired Clinverse, a provider which automates and manages the entire financial lifecycle of global clinical trials for contract research organizations (CROs) and pharmaceutical companies.
In September 2015, BioClinica acquired Synowledge, a provider of pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies with recording, analyzing and reporting adverse drug events.
In July 2015, BioClinica acquired MediciGroup, a patient recruitment and retention firm.
BioClinica Risks and Challenges
Increased consolidation among big pharma could crimp future growth for BioClinica. Additionally, changes in top management can cause some changes in product development and business operations.
BioClinica Ecosystem, Partners, Resellers and SI
BioClinica expanded its European operational capabilities by opening new offices in London and Munich to better serve its growing client base in EMEA.
Bioclinica currently works with hundreds of clinical trial outsourcing firms worldwide. Their partnerships with industry-leading technology and service companies expand the range of services available to clients. Among their partners are, MedSource, MMS Holdings, Inc., PRL Central Laboratory Services, Health Sciences International, Inc., Novella Clinical, Axio Research, Beardsworth, Kaizen Clinical Services, Inc., Symbiance, and many others
In April 2016, Bioclinica selected ArisGlobal's Safety Cloud as the preferred safety platform for its pharmacovigilance services. Under this partnership, Bioclinica becomes the preferred partner for ArisGlobal in business process consulting and change management as sponsors implement or upgrade ARISg.
BioClinica Cloud Infrastructure Insights
Subscribe to read more about:
- BioClinica Public Cloud and Infrastructure (IaaS)
- BioClinica Platform (PaaS)
- BioClinica Application Delivery
- BioClinica Private Cloud and Data Centers
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:https://www.appsruntheworld.com/About Us
Copyright © 2021, APPS RUN THE WORLD